First of all, we are all speculating about whether Surgcentre would be involved in trials. We have no idea. Second, most drug trials are run by the companies who own the product. Or someone they hire to run the trial. Either way, there is a financial incentive to consider and need to find a way to control for that. Generally, the fact that the doctors and centers have no idea whether they are giving a placebo should play a large part in minimizing the problem. Also, there would be auditing of trial procedures.
See this article that discusses some of the ways they can try to prevent conflicts from influencing trial outcomes:
https://www.centerwatch.com/articles/13288
Conflicts of interest and the clinical investigator
Ann: Mesoblast Update on Chronic Low Back Pain Program, page-197
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |